Stay updated on Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows that recruitment is closed, indicating no new participants will be enrolled. This clarifies the study's current status for participants and investigators reviewing eligibility and enrollment options.
    Difference
    0.3%
    Check dated 2026-06-13T05:12:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor site update.
    Difference
    0.0%
    Check dated 2026-06-05T22:44:30.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3, indicating a new site/template revision has been applied. This appears to be a minor metadata update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-05-15T14:40:46.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, indicating a site release rather than a change to the study’s content.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:16.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:34:53.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:11:51.000Z thumbnail image

Stay in the know with updates to Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Daratumumab in Multiple Myeloma Clinical Trial page.